1. FRI0493 THE INTERLEUKIN-1B INHIBITOR CANAKINUMAB FOR REFRACTORY STILL'S DISEASE: LONG-TERM EXPERIENCE IN 50 CONSECUTIVE PATIENTS. (2nd June 2020) Authors: Laskari, K.; Athanassiou, P.; Georgiadis, A.; Gerodimos, C.; Gkoni, G.; Daoussis, D.; Dimitroulas, T.; Dimopoulou, D.; Iliou, C.; Kallitsakis, I.; Karamitsos, D.; Katsiari, C.; Liossis, S. N.; Mavragani, C.; Papagoras, C.; Pikazis, D.; Raftakis, I.; Sarikoudis, T.; Settas, L.; Sidiropoulos, P. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗